Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Hepatology"
DOI: 10.4254/wjh.v14.i10.1862
Abstract: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and its incidence continues to increase. Despite improvements in both medical and surgical therapies, HCC remains associated with poor outcomes due to its… read more here.
Keywords: carcinoma promising; hepatocellular carcinoma; promising therapeutic; immunotherapy hepatocellular ... See more keywords